Wound Management News

Efficacy of once-weekly intravenous dalbavancin was comparable to twice-daily intravenous vancomycin for the treatment of acute bacterial skin infections, according to recent trial results.

A single dose of oritavancin was noninferior to a regimen of twice-daily vancomycin given for 7 to 10 days in treating acute bacterial skin infections, according to data from the SOLO I trial.

MRSA rates varied significantly among academic medical centers in California, Illinois, New York and North Carolina, according to study results published in Clinical Infectious Diseases.

Healio.com/Dermatology reports on five topical products used for the treatment of common skin infections.

Cosmetic skin condition treatments involving lasers, light and energy increased nearly 34% between 2012 and 2013, according to results of an American Society for Dermatologic Surgery survey of its members.

Data from multiple studies released during the 2014 European Congress of Clinical Microbiology and Infectious Diseases demonstrate the in vitro potency of telavancin and its efficacy in patients with complicated skin and skin structure infections, including MRSA.

The FDA Anti-Infective Drugs Advisory Committee has voted unanimously that dalbavancin has demonstrated substantial effectiveness and safety for the treatment of acute bacterial skin and skin structure infections caused by certain gram-positive organisms, including staphylococci and streptococci.

The FDA’s Anti-Infective Drugs Advisory Committee voted unanimously that there is substantial evidence that tedizolid is safe and effective for the treatment of acute bacterial skin and skin structure infections caused by several organisms, including MRSA.

A combination of personal hygiene and education measures, including weekly chlorhexidine bathing, did not prevent MRSA skin and soft tissue infections among high-risk military trainees, according to researchers from the Uniformed Services University of the Health Sciences.

DENVER — Advanced melanoma staging with updates on future therapies, the latest acne treatments, and laser and botulinum toxin A treatments for wounded warrior traumatic injuries are highlights of the American Academy of Dermatology annual meeting beginning today.